Key result
RT-LAMP assay specifically detects FMDV serotype O in 26 minutes without cross-reactivity.
Why the study?
Available foot-and-mouth disease virus serotyping approaches are costly, time-consuming, and require complex equipment and trained personnel.
The developed RT-LAMP assay provides a rapid, specific, and sensitive method for detecting serotype O FMDV, offering a potential tool for improved disease surveillance in endemic regions.
Foot-and-mouth disease (FMD) caused by FMD virus, is a highly infectious viral disease affecting livestock. Diagnosis plays a vital role in disease control and management during disease outbreaks. Available serotyping approaches are costly, time-consuming, requires complex equipment and trained personnel, warranting development of a diagnostic method that addresses this gap. In this retrospective study, a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the detection of serotype O FMDV was developed and evaluated using forty-three FMDV isolates from cattle. The specificity of the assay was tested against other FMDV isolates (serotypes A, SAT 1 and SAT 3). Only FMDV serotype O samples could be amplified within 26 min with an anneal derivative temperature of 87.02 degree celsius. Additionally, the assay amplified the viral protein 1 ( VP1 ) gene with a detection limit of 0.0378 ng/μl. This molecular diagnostic approach has potential future application in improving FMDV surveillance as it provides baseline information for controlling FMD outbreaks in Tanzania and other Eastern and Southern African countries.
No takes yet. Share an insight, caveat, or question.
Mueni et al. (2023) studied Foot-and-mouth disease virus (FMDV) (n=43). Reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay vs. Other FMDV serotypes (A, SAT 1, SAT 3) was evaluated on Detection limit and specificity for FMDV serotype O. The developed RT-LAMP assay specifically detected FMDV serotype O within 26 minutes with a detection limit of 0.0378 ng/µl, showing no cross-reactivity with serotypes A, SAT 1, and SAT 3.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: